| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |